Mounjaro, a GLP-1 and GIP receptor agonist, has recently captured attention for its potential in managing type 2 diabetes and aiding in weight loss. As…
Mounjaro, a GLP-1 and GIP receptor agonist, has recently captured attention for its potential in managing type 2 diabetes and aiding in weight loss. As…